While blood tests are used to rule out other forms of arthritis, the diagnosis of osteoarthritis (OA) generally relies on physical symptoms, with X-rays or MRI scans used for conformation if required. But researchers at the University of Warwick in the UK have identified a biomarker for OA that could lead to a blood test that could diagnose it, and rheumatoid arthritis (RA), years before physical symptoms present themselves.

The research borrows from a blood test used to diagnose RA, which detects anti-citrullinated protein antibodies in the blood. While it had previously been established that such antibodies are present in patients with RA as a result of the autoimmunity response of early-stage RA to the presence of citrullinated proteins (CPs) in their blood, this was not believed to be the case with OA.


More than 1,200 New Atlas Plus subscribers directly support our journalism, and get access to our premium ad-free site and email newsletter. Join them for just US$19 a year.


However, despite the lack of anti-CP antibodies in OA patients, researchers at the University of Warwick's Medical School found increased CP levels in both early-stage RA and OA patients. Through the creation of an algorithm of three biomarkers – CPs, anti-CP antibodies and hydroxyproline, a bone-derived amino acid that is the major component of collagen – the researchers found they could potentially detect and discriminate between OA and RA at the early stages, even before damage to the joints has occurred.

"This is a remarkable and unexpected finding," says Dr Naila Rabbani, the lead researcher of the study. "It could help bring early-stage and appropriate treatment for arthritis which gives the best chance of effective treatment."

"Detection of early stage-OA made the study very promising and we would have been satisfied with this only," added Dr Rabbani. "But beyond this we also found we could detect and discriminate early-stage RA and other inflammatory joint diseases at the same. This discovery raises the potential of a blood test that can help diagnose both RA and OA several years before the onset of physical symptoms."

The team's research appears in the journal Nature Scientific Reports.

Source: Warwick University